Free Trial

Virtus LifeSci Biotech Products ETF Rating

$56.82
+0.33 (+0.58%)
(As of 05/22/2024 ET)

Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2024)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

BBP Aggregate Rating

Moderate Buy
2.73

Holdings in BBP have an aggregate rating of Moderate Buy based on 597 analyst ratings issued in the past year covering 50 companies (98.4% of the portfolio).

BBP Aggregate Price Target

$83.69
47.28% Upside
High Prediction$123.98
Average Prediction$83.69
Low Prediction$60.39

Holdings in BBP have an aggregate price target of $83.69 and a range of $60.39 to $123.98 covering 50 companies (98.4% of the portfolio).

BBP Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
Moderate Buy
31 Moderate Buy rating(s)
Hold
9 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 50 BBP Holdings

Weight
In ETF
CompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
4.47%
ADMA Biologics, Inc.d stock logo
ADMA
ADMA Biologics
$9.63
+0.3%
2 of 5 stars
3.25$10.50 9.0%4
3.88%
Tarsus Pharmaceuticals, Inc.d stock logo
TARS
Tarsus Pharmaceuticals
$35.78
-5.4%
3 of 5 stars
2.88$50.38 40.8%8
3.15%
Moderna, Inc.d stock logo
MRNA
Moderna
$163.33
+13.7%
4 of 5 stars
2.24$126.46 -22.6%17High Trading Volume
3.08%
Deciphera Pharmaceuticals, Inc.d stock logo
DCPH
Deciphera Pharmaceuticals
$25.48
+0.0%
3 of 5 stars
2.30$24.17 -5.1%10
2.79%
PTC Therapeutics, Inc.d stock logo
PTCT
PTC Therapeutics
$38.64
-0.5%
2 of 5 stars
2.07$35.67 -7.7%14Analyst Forecast
Analyst Revision
News Coverage
Gap Up
2.74%
Agios Pharmaceuticals, Inc.d stock logo
AGIO
Agios Pharmaceuticals
$33.44
-1.3%
2 of 5 stars
2.50$35.00 4.7%4Analyst Downgrade
Analyst Revision
2.65%
Sarepta Therapeutics, Inc.d stock logo
SRPT
Sarepta Therapeutics
$128.30
-0.6%
5 of 5 stars
2.86$163.94 27.8%14Analyst Forecast
Options Volume
2.61%
Lexicon Pharmaceuticals, Inc.d stock logo
LXRX
Lexicon Pharmaceuticals
$1.67
2 of 5 stars
2.67$5.00 199.4%3
2.45%
Ligand Pharmaceuticals Incorporatedd stock logo
LGND
Ligand Pharmaceuticals
$87.28
+0.3%
5 of 5 stars
3.00$116.33 33.3%3
2.38%
Blueprint Medicines Co.d stock logo
BPMC
Blueprint Medicines
$102.71
-0.9%
1 of 5 stars
2.53$102.65 -0.1%17Positive News
2.35%
SpringWorks Therapeutics, Inc.d stock logo
SWTX
SpringWorks Therapeutics
$44.27
+3.0%
2 of 5 stars
3.00$68.83 55.5%6
2.24%
Neurocrine Biosciences, Inc.d stock logo
NBIX
Neurocrine Biosciences
$139.43
-0.8%
5 of 5 stars
2.79$148.96 6.8%24Insider Selling
2.21%
Kiniksa Pharmaceuticals, Ltd.d stock logo
KNSA
Kiniksa Pharmaceuticals
$19.27
-0.5%
2 of 5 stars
3.00$31.00 60.9%4
2.19%
Halozyme Therapeutics, Inc.d stock logo
HALO
Halozyme Therapeutics
$45.48
-0.1%
5 of 5 stars
2.83$53.14 16.8%6Analyst Forecast
Insider Selling
Positive News
2.19%
Amgen Inc.d stock logo
AMGN
Amgen
$309.41
-1.7%
5 of 5 stars
2.52$305.65 -1.2%21
2.16%
Regeneron Pharmaceuticals, Inc.d stock logo
REGN
Regeneron Pharmaceuticals
$983.80
-1.0%
4 of 5 stars
2.76$989.36 0.6%21
2.10%
Vertex Pharmaceuticals Incorporatedd stock logo
VRTX
Vertex Pharmaceuticals
$447.53
+1.3%
4 of 5 stars
2.48$432.18 -3.4%25Positive News
2.07%
United Therapeutics Co.d stock logo
UTHR
United Therapeutics
$276.44
+0.5%
5 of 5 stars
2.90$309.44 11.9%10Analyst Forecast
Insider Selling
2.03%
Axsome Therapeutics, Inc.d stock logo
AXSM
Axsome Therapeutics
$76.79
-1.7%
5 of 5 stars
2.92$121.92 58.8%13Options Volume
1.96%
Roivant Sciences Ltd.d stock logo
ROIV
Roivant Sciences
$11.29
+0.5%
2 of 5 stars
2.90$16.90 49.7%10Upcoming Earnings
News Coverage
Positive News
1.93%
Ascendis Pharma A/Sd stock logo
ASND
Ascendis Pharma A/S
$131.14
+6.7%
1 of 5 stars
2.88$176.88 34.9%8Analyst Upgrade
High Trading Volume
1.92%
Intra-Cellular Therapies, Inc.d stock logo
ITCI
Intra-Cellular Therapies
$67.30
+0.4%
5 of 5 stars
2.90$90.17 34.0%10Positive News
1.83%
BioCryst Pharmaceuticals, Inc.d stock logo
BCRX
BioCryst Pharmaceuticals
$6.66
+3.7%
4 of 5 stars
3.00$14.00 110.2%7Positive News
Gap Up
1.78%
BeiGene, Ltd.d stock logo
BGNE
BeiGene
$167.92
+0.3%
3 of 5 stars
2.80$251.93 50.0%10Positive News
Gap Down
1.74%
Rhythm Pharmaceuticals, Inc.d stock logo
RYTM
Rhythm Pharmaceuticals
$37.84
-0.4%
3 of 5 stars
2.83$54.33 43.6%6
1.73%
Ultragenyx Pharmaceutical Inc.d stock logo
RARE
Ultragenyx Pharmaceutical
$41.08
+1.2%
4 of 5 stars
2.92$87.85 113.8%12
1.73%
Exelixis, Inc.d stock logo
EXEL
Exelixis
$21.00
-0.1%
5 of 5 stars
2.59$26.13 24.4%17Insider Selling
1.73%
Biogen Inc.d stock logo
BIIB
Biogen
$225.21
-1.1%
5 of 5 stars
2.65$288.46 28.1%26Analyst Forecast
1.72%
Incyte Co.d stock logo
INCY
Incyte
$58.20
+1.4%
5 of 5 stars
2.47$74.93 28.8%18Analyst Forecast
1.71%
BioNTech SEd stock logo
BNTX
BioNTech
$102.30
+11.1%
0 of 5 stars
2.20$111.70 9.2%10Options Volume
High Trading Volume
1.70%
Insmed Incorporatedd stock logo
INSM
Insmed
$24.16
-1.5%
4 of 5 stars
3.00$44.71 85.1%14
1.69%
CRISPR Therapeutics AGd stock logo
CRSP
CRISPR Therapeutics
$56.80
+3.7%
3 of 5 stars
2.35$73.93 30.2%17
1.69%
Harmony Biosciences Holdings, Inc.d stock logo
HRMY
Harmony Biosciences
$30.19
+1.8%
4 of 5 stars
2.50$40.63 34.6%8Positive News
1.59%
Immunocore Holdings plcd stock logo
IMCR
Immunocore
$50.47
-1.0%
2 of 5 stars
2.87$81.85 62.2%15High Trading Volume
1.59%
Gilead Sciences, Inc.d stock logo
GILD
Gilead Sciences
$67.80
+0.8%
5 of 5 stars
2.35$83.69 23.4%17
1.59%
Apellis Pharmaceuticals, Inc.d stock logo
APLS
Apellis Pharmaceuticals
$43.60
+2.4%
5 of 5 stars
2.87$76.67 75.8%15Positive News
1.58%
Theravance Biopharma, Inc.d stock logo
TBPH
Theravance Biopharma
$8.98
-1.5%
2 of 5 stars
3.00$20.50 128.3%2Analyst Upgrade
1.58%
BridgeBio Pharma, Inc.d stock logo
BBIO
BridgeBio Pharma
$29.27
0.0%
4 of 5 stars
2.91$47.67 62.9%11Analyst Forecast
Analyst Revision
1.54%
Alnylam Pharmaceuticals, Inc.d stock logo
ALNY
Alnylam Pharmaceuticals
$150.90
+0.9%
5 of 5 stars
2.59$216.19 43.3%17
1.51%
BioMarin Pharmaceutical Inc.d stock logo
BMRN
BioMarin Pharmaceutical
$76.45
-1.2%
5 of 5 stars
2.57$106.11 38.8%21
1.50%
Amicus Therapeutics, Inc.d stock logo
FOLD
Amicus Therapeutics
$9.72
-1.9%
5 of 5 stars
2.86$17.50 80.0%7Gap Up
1.49%
Ionis Pharmaceuticals, Inc.d stock logo
IONS
Ionis Pharmaceuticals
$38.00
+1.7%
5 of 5 stars
2.71$59.54 56.7%14
1.42%
Legend Biotech Co.d stock logo
LEGN
Legend Biotech
$42.60
-0.8%
2 of 5 stars
2.91$82.74 94.2%11
1.40%
Mirum Pharmaceuticals, Inc.d stock logo
MIRM
Mirum Pharmaceuticals
$26.22
+1.7%
4 of 5 stars
3.10$49.73 89.7%10
1.37%
Travere Therapeutics, Inc.d stock logo
TVTX
Travere Therapeutics
$6.56
-0.8%
1 of 5 stars
2.62$15.58 137.6%13
1.32%
Zai Lab Limitedd stock logo
ZLAB
Zai Lab
$20.16
+0.7%
2 of 5 stars
3.00$64.22 218.6%5Gap Down
1.23%
Aurinia Pharmaceuticals Inc.d stock logo
AUPH
Aurinia Pharmaceuticals
$5.53
-1.1%
3 of 5 stars
2.75$10.00 80.8%4
1.07%
Ironwood Pharmaceuticals, Inc.d stock logo
IRWD
Ironwood Pharmaceuticals
$6.49
-4.3%
4 of 5 stars
3.00$18.40 183.5%5Analyst Revision
1.03%
ACADIA Pharmaceuticals Inc.d stock logo
ACAD
ACADIA Pharmaceuticals
$15.82
+3.6%
4 of 5 stars
2.75$28.94 82.9%16
1.01%
Sage Therapeutics, Inc.d stock logo
SAGE
Sage Therapeutics
$12.10
+0.4%
4 of 5 stars
2.12$37.67 211.3%17
This page (NYSEARCA:BBP) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners